Cabaletta Bio (CABA) Accumulated Expenses (2018 - 2025)

Cabaletta Bio has reported Accumulated Expenses for 8 years, with the latest figure at $9.7 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 16.85% year-over-year to $9.7 million; the trailing twelve-month figure through Dec 2025 stood at $9.7 million (up 16.85% YoY), and the FY2025 full-year result was $9.7 million, up 16.85% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $9.7 million, up from $6.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $13.9 million in Q2 2025, with the low at $651000.0 in Q1 2021.
• Average Accumulated Expenses over 5 years is $5.1 million, with a median of $3.7 million recorded in 2022.
• Year-over-year, Accumulated Expenses surged 364.67% in 2022 and slumped 67.11% in 2023.
• Tracing CABA's Accumulated Expenses over 5 years: stood at $6.0 million in 2021, then declined by 19.84% to $4.8 million in 2022, then soared by 62.72% to $7.9 million in 2023, then grew by 5.43% to $8.3 million in 2024, then gained by 16.85% to $9.7 million in 2025.
• The last three Accumulated Expenses figures came in at $9.7 million (Q4 2025), $6.8 million (Q3 2025), and $13.9 million (Q2 2025), per Business Quant data.

Peer Comparison